Epidemiology of Hepatitis B virus and genotype

Journal of Clinical Virology

Volumn 36, Issue SUPPL. 1, 2006, Pages

  Allain, Jean Pierre ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Genotype; HBV; Natural history; Phylogeny

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY;

ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; DISEASE TRANSMISSION; GENOTYPE; HEPATITIS B; HUMAN; LIVER TRANSPLANTATION; NONHUMAN; ORGAN DONOR; PREVALENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEROCONVERSION; VIRUS LOAD; VIRUS REPLICATION; VIRUS STRAIN;

GENOTYPE; HEPATITIS B; HUMANS;

EID: 33745737777     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(06)80003-X     Document Type: Article

References (47)

1. Allain J. Occult hepatitis B virus infection: implications in transfusion. Vox Sang 86 (2004) 83-91
2. Allain J., Hewitt P., Tedder R., and Williamson L. Evidence that anti-HBc but not HBV DNA testing may prevent some HBV transmission by transfusion. Br J Haematol 107 (1999) 186-195
3. Allain J., Candotti D., Soldan K., Sarkodie F., Phelps B., Giachetti C., et al. The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana. Blood 101 (2003) 2419-2425
4. Amarapenkar D., Baijal R., Kulthrestha P., Agal S., Chakraberty M., and Pramanik S. Profile of hepatitis B e antigen-negative chronic hepatitis B. Indian J Gastroenterology 21 (2002) 99-101
5. Aoki S., Finegold D., Kuramoto I., Richards C., Randell R., Fernando L., et al. Significance of antibody to hepatitis B core antigen in blood donors as determined by their serological response to hepatitis B vaccine. Transfusion 33 (1993) 362-367
6. Biswas R., Tabor E., Hsia C., Wright D., Laycock M., Fiebig E., et al. Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection. Transfusion 43 (2003) 788-798
7. Blajchman M., Bull S., and Feinman S. Post-transfusion hepatitis: impact of non-A, non-B surrogate tests. Lancet 345 (1995) 21-25
8. Burkh R., Hwang L., Ho G., Shafritz D., and Beasley R. Outcome of perinatal hepatitis B virus exposure is dependent on maternal viral load. J Inf Dis 170 (1994) 1418-1423
9. in press. Candotti D., Opare-Sem O., Rezvan H., Sarkodie F., and Allain J. Molecular and serological characterization of hepatitis B virus in deferred Ghanaian blood donors with and without elevated alanine aminotransferase. J Hepatitis (2006)
10. Chu C., Hussain M., and Lok A. Hepatitis B virus genotype B is associated with earlier HBsAg seroconversion compared with hepatitis B virus genotype C. Gastroenterology 122 (2002) 1756-1762
11. Chu C., Hung S., Lin J., Tai D., and Liaw Y. Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels. Am J Med 116 (2004) 829-834
12. Davidson F., Lycett C., Sablon E., Petrik J., and Dow B. Hepatitis B virus genotypes and precore mutations in Scottish blood donors. Vox Sang 88 (2005) 87-92
13. Dickson R., Everhart J., Lake J., Wei Y., Seaberg E., Wiesner R., et al. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. Gastroenterology 113 (1997) 1668-1674
14. Grandjacques C., Pradat P., Stuyver L., Chevallier M., Chevallier P., Pichoud C., et al. Rapid detection of genotypes and mutations in the pre-core promoter and the pre-core region of hepatitis B virus genome: correlation with viral persistence and disease severity. J Hepatol 33 (2000) 430-439
15. Hasan K., Rumi M., Hasanat M., Azam M., Ahmed S., Salam M., et al. Chronic carriers of the hepatitis B virus in Bangladesh: a comparative analysis of HBV DNA, HBeAg/anti-HBe and liver function tests. Southeast Asian J Trop Med Public Health 33 (2002) 110-117
16. Hennig H., Puchta I., Luhm J., Schlenke P., Goerg S., and Kirchner H. Frequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis B core antigen. Blood 100 (2002) 2637-2641
17. Ip H., Lelie P., Wong V., Kuhns M., and Reesink H. Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA. Lancet 1 (1989) 406-410
18. Jardi R., Rodriguez F., Buti M., Costa X., Cotrina M., Valdes A., et al. Quantitative detection of hepatitis B virus DNA in serum by a new rapid real-time fluorescence PCR assay. J Viral Hepatitis 8 (2001) 465-471
19. Kessler H., Preininger S., Stelzl E., Daghofer E., Santner B., Marth E., et al. Identification of different states of hepatitis B virus infection with quantitative PCR assay. Clin Diag Lab Immunol 7 (2000) 298-300
20. Kimura T., Rokuhara A., Matsumoto A., Yagi S., Tanaka E., Kiyosawa K., et al. New enzyme immunoassay for detection of hepatitis B virus core antigen (HbcAg) and relation between levels of HbcAg and HBV DNA. J Clin Microbiol 41 (2003) 1901-1906
21. Kleinman S., Strong D., Tegtmeier G., Holland P., Gorlin J., Cousins C., et al. Hepatitis B virus (HBV) DNA screening of blood donations in minipools with COBAS ampliscreen HBV test. Transfusion 45 (2005) 1247-1257
22. Kuhns M., Kleinman S., McNamara A., Rawal B., Glynn S., and Busch M. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy. Transfusion 44 (2004) 1332-1339
23. Loeb K., Jerome K., Goddard J., Huang M., Cent A., and Corey L. High-throughput quantitative analysis of hepatitis B virus DNA in serum using the Taqman fluorogenic detection system. Hepatology 32 (2000) 626-629
24. Lopez V., Bourne E., Lutz M., and Condreay L. Assessment of the COBAS Amplicor monitor test for quantitation of serum hepatitis B virus DNA levels. J Clin Microbiol 40 (2002) 1972-1976
25. Michalak T., Pasquinelli C., Guilhot S., and Chisari F. Hepatitis B virus persistence after recovery from acute viral hepatitis. J Clin Invest 93 (1994) 230-239
26. Mosley J., Stevens C., Aach R., Hollinger F., Mimms L., Solomon L., et al. Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients. Transfusion 35 (1995) 5-12
27. Murokawa H., Yoshikawa A., Ohnuma H., Iwata A., Katoh N., Miyamoto M., et al. Epidemiology of blood donors in Japan, positive for hepatitis B virus and hepatitis C virus by nucleic acid amplification testing. Vox Sang 88 (2005) 10-16
28. Nogales M., Serrano M., Suarez E., Corpas R., Perez L., Claro R., et al. Determination of hepatitis B virus genotype and detection of lamivudine-resistance mutations. Gastroenterol Hepatol 27 (2004) 515-520
29. Ohkubo K., Kato Y., Ichikawa T., Kajiya Y., Takeda Y., Higashi S., et al. Viral load is a significant prognostic factor for hepatitis B virus-associated hepatocellular carcinoma. Cancer 94 (2002) 2663-2668
30. Owusu-Ofori S., Temple J., Sarkodie F., Anokwa M., Candotti D., and Allain J. Pre-donation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings. Transfusion 45 (2005) 133-140
31. Pang A., Yuen M., Yuan H., Lai C., and Kwong Y. Real-time quantification of hepatitis B virus core-promoter and pre-core mutants during hepatitis e antigen seroconversion. J Hepatol 40 (2004) 1008-1017
32. Pas S., Fries E., De Man R., Oserhaus A., and Niesters H. Development of a quantitative real-time detection assay for hepatitis B virus DNA and comparison with two commercial assays. J Clin Microbiol 38 (2000) 2897-2901
33. Perez-Olmeda M., Nunez M., Garcia-Samaniego J., Rios P., Gonzalez-Lahoz J., and Soriano V. Distribution of hepatitis B virus genotypes in HIV-infected patients with chronic hepatitis B: therapeutic implications. AIDS Res Hum Retroviruses 19 (2003) 657-659
34. Pillonel J., and Laperche S. Risque residuel de transmission du VIH, du VHC et du VHB par transfusion sanguine entre 1992 et 2002 en France et impact du depistage genomique vital. Transfus Clin Biol 11 (2004) 81-86
35. Prince A., Lee D., and Brotman B. Infectivity of blood from PCR-positive, HBsAg negative, anti-HBs positive cases of resolved hepatitis B infection. Transfusion 41 (2001) 329-332
36. Rehermann B., Ferrari C., Pasquinelli C., and Chisari F. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 2 (1996) 1104-1108
37. Ren F., Li H., and Zhao H. Studies on hepatitis B virus infection in blood donors with positive anti-HBc and negative HBsAg. Zhonghua Yu Fang Yi Xue Za Zhi 32 (1998) 7-9
38. Roche B., Samuel D., Gigou M., Feray C., Virot V., Schmets L., et al. De novo and apparent de novo hepatitis B virus infection after liver transplantation. J Hepatol 26 (1997) 517-526
39. Roth W., Weber M., Petersen D., Drosten C., Buhr S., Sireis W., et al. NAT for HBV and anti-HBc testing increase blood safety. Transfusion 42 (2002) 869-875
40. Sanchez-Tapias J., Costa J., Mas A., Bruguera M., and Rodes J. Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in Western patients. Gastroenterology 123 (2002) 1845-1856
41. Sato S., Ohashi W., Ihara H., Sakaya S., Kato T., and Ikeda H. Comparison of the sensitivity of NAT using pooled donor samples for HBV and that of a serologic HBsAg assay. Transfusion 41 (2001) 1107-1113
42. Schifman R., Rivers S., Sampliner R., and Krammes J. Significance of isolated hepatitis B core antibody in blood donors. Arch Intern Med 153 (1993) 2261-2266
43. Suzuki S., Sugauchi F., Orito E., Kato H., Usada S., Siransy L., et al. Distribution of hepatitis B virus (HBV) genotypes among HBV carriers in the Cote d'Ivoire: complete genome sequence and phylogenetic relatedness of HBV genotype E. J Med Virol 69 (2003) 459-465
44. Uemoto S., Sugiyama K., Marusawa H., Inomata Y., Asonuma K., Egawa H., et al. Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants. Transplantation 65 (1998) 494-499
45. Weiss J., Wu H., Farrenkopf B., Schultz T., Song G., Shah S., et al. Real time Taqman PCR dtectection and quantitation of HBV genotypes A-G with the use of an internal quantitation standard. J Clin Virol 30 (2004) 86-93
46. Yalcin K., Degertekin H., Yildiz F., and Celik Y. Markers of disease activity in chronic hepatitis B virus infection. Clin Invest Med 26 (2003) 27-34
47. Yoshikawa A., Gotanda Y., Itabashi M., Minegishi K., Kanemitsu K., and Nishioka K. Hepatitis B NAT virus-positive blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNA. Vox Sang 88 (2005) 77-86